Stability Analysis of Vascular Endothelial Growth Factor in Cerebrospinal Fluid

被引:8
|
作者
Yang, Jun [1 ]
Dombrowski, Stephen M. [1 ]
Deshpande, Abhishek [1 ]
Krajcir, Natalie [1 ]
El-Khoury, Serge [1 ]
Krishnan, Chandra [1 ]
Luciano, Mark G. [1 ]
机构
[1] Cleveland Clin, Dept Neurol Surg, Sect Pediat & Congenital Neurol Surg, CSF Physiol Lab,Neurol Inst, Cleveland, OH 44195 USA
关键词
Cell count; Centrifugation; Temperature; Time; Preservation; BLOOD-VESSEL DENSITY; PERIPHERAL-BLOOD; FACTOR VEGF; CHRONIC HYDROCEPHALUS; PLATELET ACTIVATION; T-CELLS; CANCER; RELEASE; ANGIOGENESIS; EXPRESSION;
D O I
10.1007/s11064-011-0517-z
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Vascular endothelial growth factor (VEGF) is a promising biological marker and prognostic indicator in many neurological diseases. Although VEGF concentrations in plasma and cerebrospinal fluid (CSF) are increasingly reported, CSF-VEGF stability pre- and during-assay procedures is seldom evaluated. In the current study, we investigated VEGF variability and stability in CSF related to sample preparation, storage, and routine experimental procedures. Results showed that contaminant cell breakdown or aggregation can occur gradually before sample processing. However, after the removal of contaminant cell components, CSF-VEGF levels did not show significant changes in samples incubated at room temperature for 5 h, thawed/refrozen for 6 cycles. Samples preserved at -80 degrees C for up to 7 years continued to show measurable levels. Since some cellular components such as platelets contain a large amount of releasable VEGF, we conclude that CSF samples should be processed as soon as possible to carefully remove all cellular components and prevent possible consequent release of VEGF into CSF. After centrifugation to remove cellular contents, VEGF in CSF was relatively stable during routine experimental procedures and storage.
引用
收藏
页码:1947 / 1954
页数:8
相关论文
共 50 条
  • [21] Vascular endothelial growth factor and transforming growth factor-β1 are highly expressed in the cerebrospinal fluid of premature infants with posthemorrhagic hydrocephalus
    Heep, A
    Stoffel-Wagner, B
    Bartmann, P
    Benseler, S
    Schaller, C
    Groneck, P
    Obladen, M
    Felderhoff-Mueser, U
    PEDIATRIC RESEARCH, 2004, 56 (05) : 768 - 774
  • [22] Cerebrospinal Fluid Ceruloplasmin, Haptoglobin, and Vascular Endothelial Growth Factor Are Associated with Neurocognitive Impairment in Adults with HIV Infection
    Kallianpur, A. R.
    Gittleman, H.
    Letendre, S.
    Ellis, R.
    Barnholtz-Sloan, J. S.
    Bush, W. S.
    Heaton, R.
    Samuels, D. C.
    Franklin, D. R., Jr.
    Rosario-Cookson, D.
    Clifford, D. B.
    Collier, A. C.
    Gelman, B.
    Marra, C. M.
    McArthur, J. C.
    McCutchan, J. A.
    Morgello, S.
    Grant, I.
    Simpson, D.
    Connor, J. R.
    Hulgan, T.
    McArthur, Justin
    Morgello, Susan
    Simpson, David
    McCutchan, J. Allen
    Collier, Ann
    Marra, Christina
    Clifford, David
    Gelman, Benjamin
    MOLECULAR NEUROBIOLOGY, 2019, 56 (05) : 3808 - 3818
  • [23] Cerebrospinal fluid and serum vascular endothelial growth factor and nitric oxide levels in newborns with hypoxic ischemic encephalopathy
    Ergenekon, E
    Gücüyener, K
    Erbas, D
    Aral, S
    Koç, E
    Atalay, Y
    BRAIN & DEVELOPMENT, 2004, 26 (05): : 283 - 286
  • [24] Cerebrospinal Fluid Ceruloplasmin, Haptoglobin, and Vascular Endothelial Growth Factor Are Associated with Neurocognitive Impairment in Adults with HIV Infection
    A. R. Kallianpur
    H. Gittleman
    S. Letendre
    R. Ellis
    J. S. Barnholtz-Sloan
    W. S. Bush
    R. Heaton
    D. C. Samuels
    D. R. Franklin
    D. Rosario-Cookson
    D. B. Clifford
    A. C. Collier
    B. Gelman
    C. M. Marra
    J. C. McArthur
    J. A. McCutchan
    S. Morgello
    I. Grant
    D. Simpson
    J. R. Connor
    T. Hulgan
    Molecular Neurobiology, 2019, 56 : 3808 - 3818
  • [25] Vascular endothelial growth factor concentrations in the cerebrospinal fluid of dogs with neoplastic or inflammatory central nervous system disorders
    Mariani, Christopher L.
    Niman, Zachary E.
    Boozer, Lindsay B.
    Ruterbories, Laura K.
    Early, Peter J.
    Munana, Karen R.
    Olby, Natasha J.
    JOURNAL OF VETERINARY INTERNAL MEDICINE, 2021, 35 (04) : 1873 - 1883
  • [26] Low levels of vascular endothelial growth factor in cerebrospinal fluid from early amyotrophic lateral sclerosis patients
    Brunaud-Danel, V
    Moreau, C
    Lassalle, R
    Perez, T
    De Seze, J
    Defebvre, L
    Tonnel, A
    Just, N
    Devos, D
    Destée, A
    JOURNAL OF NEUROLOGY, 2004, 251 : 30 - 30
  • [27] Vascular endothelial growth factor (VEGF) and matrix metalloprotease (MMP) cerebrospinal fluid (CSF) biomarkers in lymphomatous meningitis
    Yu, Min
    Song, Susan
    Nguyen, Songklha
    Jeyapalan, Suriya
    Groves, Morris
    Swanson, Kenneth
    Gautam, Shiva
    Wong, Eric
    NEURO-ONCOLOGY, 2007, 9 (04) : 548 - 548
  • [28] Exercise-induced changes of cerebrospinal fluid vascular endothelial growth factor in adult chronic hydrocephalus patients
    Yang, Jun
    Shanahan, Kaitlyn J.
    Shriver, Leah P.
    Luciano, Mark G.
    JOURNAL OF CLINICAL NEUROSCIENCE, 2016, 24 : 52 - 56
  • [29] Vascular endothelial growth factor is increased in cerebrospinal fluid after traumatic brain injury in infants and children - Comments
    Robertson, CS
    Proctor, MR
    Scott, RM
    Sutton, LN
    Aryan, HE
    Levy, ML
    NEUROSURGERY, 2004, 54 (03) : 611 - 612
  • [30] The Role of Vascular Endothelial Growth Factor and Vascular Stability in Diseases of the Ear
    London, Nyall R.
    Gurgel, Richard K.
    LARYNGOSCOPE, 2014, 124 (08): : E340 - E346